A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors

Clinical trial NCT06970795 · RECRUITING

Trial details

NCT number: NCT06970795
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer Other Advanced Solid Tumors

Start date: 2025-04-10
Primary completion: 2027-02-28
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.